(Q40741038)

23 September 2017

title

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322557

13 September 2022

main subject

Cytomegalovirus

0 references

cytomegaloviral disease

1 reference

3

Ljungman P

1 reference

23 September 2017

Ringdén O

2

1 reference

23 September 2017

J. Aschan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322557

13 September 2022

O. Ringdén

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322557

13 September 2022

B. Lönnqvist

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322557

13 September 2022

S. Ohlman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322557

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1322557

13 September 2022

publication date

1 January 1992

1 reference

23 September 2017

1 reference

23 September 2017

volume

24

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

143-150

1 reference

A Prospective Analysis of Interstitial Pneumonia and Opportunistic Viral Infection among Recipients of Allogeneic Bone Marrow Grafts

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Effect of adenine arabinoside on cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Antiviral effects of phosphonoformate (PFA, foscarnet sodium).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

An interchangeable elisa for cytomegalovirus antigen and antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549209052604

10.3109/00365549209052604

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference